Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Wantai biology announced that it plans to raise no more than 3.5 billion yuan for the phase II expansion construction project of nine price cervical cancer vaccine, the industrialization project of twenty price pneumococcal polysaccharide conjugate vaccine, the construction project of Xiamen Wantai diagnostic base of Yangshengtang and the construction project of nasal spray vaccine industrial base.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.
Mar 30, 2023 04:00 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Oct 19, 2021 06:56 AM
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Sep 17, 2021 11:58 AM
· Technology
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary, Industrials, Consumer Staples · Analysis
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
May 12, 2023 01:33 PM